Summarized by Masters of Longevity from Longevity Technology.
A poster reported one Alzheimer’s patient with 12 months of NK cell therapy follow-up.
Key Takeaways
- NKGen presented one Alzheimer’s patient with twelve months follow-up.
- The therapy reinfused expanded natural killer cells from blood.
- These single-patient results remain preliminary and cannot prove efficacy.
